Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide for Advanced Hepatocellular Cancer
NCT00717756Phase 2Completed
- Sponsor
- Brown University
- Start
- Jan 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide in hepatocellular carcinoma (HCC), sponsored by Brown University. Primary endpoint: Response Rate by Recist Criteria. Started Jan 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00717756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717756.